ClinicalTrials.Veeva

Menu

Randomized Trial of Alerts in Patients Demonstrating a "Triple Low"

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Low Mean Arterial Blood Pressure
Low End-tidal Anesthetic Concentration
Low Bispectral Index

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators propose to test the theory that smart alarms for the Triple Low State incorporated into a decision support system built into an electronic anesthesia record will prompt clinicians to intervene earlier in situations that would otherwise provoke little concern, and that the alert system will reduce 90-day mortality. Specifically, the investigators will test the hypothesis that providing Triple Low alerts reduces 90-day mortality.

Enrollment

9,846 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults presenting for non-cardiac surgery under volatile general anesthesia

Trial design

9,846 participants in 2 patient groups

decision-support alerts
Description:
In patients experiencing a Triple Low (a combination of low MAC, low MAP, and low BIS), a warning alert will be generated for clinicians.
routine practice
Description:
In patients experiencing a Triple Low (a combination of low MAC, low MAP, and low BIS), a warning alert will not be generated for clinicians.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems